9 METERS BIOPHARMA INC's ticker is NMTR and the CUSIP is 654405109. A total of 1 filers reported holding 9 METERS BIOPHARMA INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $29,000 | -17.1% | 133,105 | 0.0% | 0.00% | – |
| Q2 2022 | $35,000 | -90.7% | 133,105 | -78.8% | 0.00% | – |
| Q1 2022 | $376,000 | -38.7% | 627,200 | 0.0% | 0.00% | – |
| Q4 2021 | $613,000 | -23.0% | 627,200 | +2.6% | 0.00% | – |
| Q3 2021 | $796,000 | +50.2% | 611,566 | +27.0% | 0.00% | – |
| Q2 2021 | $530,000 | +679.4% | 481,547 | +727.7% | 0.00% | – |
| Q1 2021 | $68,000 | – | 58,176 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ghost Tree Capital, LLC | 2,750,000 | $3,575,000 | 1.04% |
| ODonnell Financial Services, LLC | 840,727 | $1,093,000 | 0.52% |
| Orbimed Advisors | 8,565,974 | $11,136,000 | 0.12% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 15,000,000 | $19,500,000 | 0.04% |
| Paradigm, Strategies in Wealth Management, LLC | 30,800 | $40,000 | 0.04% |
| Ascent Wealth Partners, LLC | 85,224 | $111,000 | 0.02% |
| CHARTWELL INVESTMENT PARTNERS, LLC | 475,839 | $619,000 | 0.02% |
| Prentice Wealth Management LLC | 29,000 | $38,000 | 0.02% |
| Valeo Financial Advisors, LLC | 198,148 | $258,000 | 0.02% |
| Summit X, LLC | 15,300 | $21,000 | 0.01% |